PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of thoraxThoraxVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
Thorax. 1984 September; 39(9): 668–672.
PMCID: PMC459896

Comparative trial of two non-sedative H1 antihistamines, terfenadine and astemizole, for hay fever.

Abstract

Ninety patients participated in a randomised, double blind, placebo controlled comparison of terfenadine with astemizole in the treatment of hay fever. They entered the trial as a cohort before the grass pollen season and recorded daily their symptoms of itching eyes, sneezing, running nose, and blocked nose on visual analogue scales in diary cards. Over the eight weeks of the trial astemizole was significantly better than either terfenadine or placebo in alleviating itching eyes, sneezing, and running nose (p less than 0.0001) but no better than placebo for the treatment of blocked nose. The placebo was significantly better than terfenadine for the treatment of running nose and blocked nose (p less than 0.002). Neither of these H1 antihistamine drugs was associated with sedative adverse effects despite significantly inhibiting histamine induced skin weal responses. These results suggest that astemizole is a satisfactory non-sedative H1 antihistamine for maintenance treatment of hay fever. Terfenadine is ineffective by comparison.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (623K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Backhouse CI, Brewster BS, Lockhart JD, Maneksha S, Purvis CR, Vallé-Jones JC. Terfenadine in allergic rhinitis. A comparative trial of a new antihistamine versus chlorpheniramine and placebo. Practitioner. 1982 Feb;226(1364):347–351. [PubMed]
  • Small P, Barrett D, Biskin N, Champlin E. Chronic urticaria and angioedema. Clin Allergy. 1982 Mar;12(2):131–136. [PubMed]
  • Howarth PH, Emanuel MB, Holgate ST. Astemizole, a potent histamine H1-receptor antagonist: effect in allergic rhinoconjunctivitis, on antigen and histamine induced skin weal responses and relationship to serum levels. Br J Clin Pharmacol. 1984 Jul;18(1):1–8. [PubMed]
  • Nicholson AN, Stone BM. Performance studies with the H1-histamine receptor antagonists, astemizole and terfenadine. Br J Clin Pharmacol. 1982 Feb;13(2):199–202. [PubMed]
  • Nicholson AN, Smith PA, Spencer MB. Antihistamines and visual function: studies on dynamic acuity and the pupillary response to light. Br J Clin Pharmacol. 1982 Nov;14(5):683–690. [PubMed]
  • Garteiz DA, Hook RH, Walker BJ, Okerholm RA. Pharmacokinetics and biotransformation studies of terfenadine in man. Arzneimittelforschung. 1982;32(9A):1185–1190. [PubMed]
  • Laduron PM, Janssen PF, Gommeren W, Leysen JE. In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole. Mol Pharmacol. 1982 Mar;21(2):294–300. [PubMed]
  • Naclerio RM, Meier HL, Kagey-Sobotka A, Adkinson NF, Jr, Meyers DA, Norman PS, Lichtenstein LM. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis. 1983 Oct;128(4):597–602. [PubMed]
  • Dugue P, Birnbaum J, Poisson A, Charpin J. Clinical studies with terfenadine in seasonal allergic rhinitis in France. Arzneimittelforschung. 1982;32(9A):1206–1208. [PubMed]
  • Brewster BS. Summary of four UK clinical trials with terfenadine. Arzneimittelforschung. 1982;32(9A):1213–1214. [PubMed]
  • Thithapandha A, Cohn VH. Brain histamine N-methyltransferase purification, mechanism of action, and inhibition by drugs. Biochem Pharmacol. 1978 Feb 1;27(3):263–271. [PubMed]

Articles from Thorax are provided here courtesy of BMJ Group